New drug duo battles tough pancreatic cancer
NCT ID NCT04820179
Summary
This study is testing whether a combination of two drugs, atezolizumab and cabozantinib, can help control advanced pancreatic cancer that has spread and stopped responding to standard chemotherapy. It will involve about 30 patients to see if the treatment is safe and if it can shrink tumors, slow disease progression, or extend life. The goal is to find a new treatment option for a cancer with very limited choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
Conditions
Explore the condition pages connected to this study.